Patients' findings after COVID-19 infection and vaccinations : what to expect from [18F]FDG PET/CT
| Errataetall: |
CommentIn: Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1099-1100. - PMID 35079848 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
European journal of nuclear medicine and molecular imaging - 49(2022), 3 vom: 22. Feb., Seite 791-795 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sollini, Martina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0Z5B2CJX4D |
|---|
| Anmerkungen: |
Date Completed 03.02.2022 Date Revised 21.03.2022 published: Print CommentIn: Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1099-1100. - PMID 35079848 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00259-021-05652-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334644461 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334644461 | ||
| 003 | DE-627 | ||
| 005 | 20231225224138.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-021-05652-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1115.xml |
| 035 | |a (DE-627)NLM334644461 | ||
| 035 | |a (NLM)34928399 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sollini, Martina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Patients' findings after COVID-19 infection and vaccinations |b what to expect from [18F]FDG PET/CT |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2022 | ||
| 500 | |a Date Revised 21.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1099-1100. - PMID 35079848 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 7 | |a Radiopharmaceuticals |2 NLM | |
| 650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
| 650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
| 700 | 1 | |a Gelardi, Fabrizia |e verfasserin |4 aut | |
| 700 | 1 | |a Biroli, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Chiti, Arturo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d 2002 |g 49(2022), 3 vom: 22. Feb., Seite 791-795 |w (DE-627)NLM116957360 |x 1619-7089 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2022 |g number:3 |g day:22 |g month:02 |g pages:791-795 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00259-021-05652-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2022 |e 3 |b 22 |c 02 |h 791-795 | ||